Skip to Content
Merck

03-34-0001

H-Gly-Pro-Arg-Pro-OH

Inhibitor of fibrinogen aggregation and fibrin polymerization.

Synonym(s):

H-Gly-Pro-Arg-Pro-OH

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Empirical Formula (Hill Notation):
C18H31N7O5
CAS Number:
Molecular Weight:
425.48
UNSPSC Code:
12352202
NACRES:
NA.32
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

H-Gly-Pro-Arg-Pro-OH, Inhibitor of fibrinogen aggregation and fibrin polymerization.

SMILES string

N2([C@@H](CCC2)C(=O)O)C(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)CN)CCCN=C(N)N

InChI

1S/C18H31N7O5/c19-10-14(26)24-8-2-5-12(24)15(27)23-11(4-1-7-22-18(20)21)16(28)25-9-3-6-13(25)17(29)30/h11-13H,1-10,19H2,(H,23,27)(H,29,30)(H4,20,21,22)/t11-,12-,13-/m0/s1

InChI key

WXPZDDCNKXMOMC-AVGNSLFASA-N

assay

≥98% (HPLC)

form

lyophilized

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze
desiccated

technique(s)

protein extraction: suitable

solubility

5% acetic acid: 1 mg/mL

shipped in

ambient

storage temp.

−20°C

Quality Level

Biochem/physiol Actions

Cell permeable: no
Product does not compete with ATP.
Reversible: no

Disclaimer

Toxicity: Standard Handling (A)

General description

Inhibitor of fibrinogen aggregation and fibrin polymerization.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Barnard, M.R., et al. 1999. Transfusion39, 73.
Rijkers, D.T., et al. 1998. Thromb. Res. 89, 161.
Achyuthan, K.E., and Dobson, J.V. 1986. Biochim. Biophys. Acta872, 261.

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Yiyuan Zhang et al.
Thrombosis research, 192, 141-151 (2020-06-02)
Kinase inhibitors can pose bleeding risks as platelet signaling evolves during clotting. Using microfluidics (200 s-1 wall shear rate) to perfuse Factor XIIa-inhibited or thrombin-inhibited whole blood (WB) over collagen ± tissue factor (TF), we explored the potency of the Src family kinase

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service